Search for: "Drake v. State" Results 321 - 339 of 339
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2011, 9:30 am by ipelton
The Board cited the recent meeting and orders in Blackhorse .v Pro Football, Inc. [read post]
25 Oct 2011, 2:16 pm by Lyle Denniston
The Court may consider as early as its Conference this Friday the motion to dismiss the case of Knox v. [read post]
20 Dec 2007, 7:47 am
Title V/CSHCN has supported care notebooks for families and hired parent advocates around the state. [read post]
21 Dec 2009, 3:06 am
Hamilton (Drake), Gregg W. [read post]
8 Aug 2017, 4:58 pm by Jamie Baker
Drake, You Can’t Write Without Research: The Role of Research Instruction in the Upper-Level Writing Requirement, 18 FLA. [read post]
8 Jun 2018, 12:30 pm by Dan Ernst
  THURSDAY The Rights Revolution in Action: The Transformation of State Institutions after the 1960sThu, 6/7: 8:00 AM—9:45 AM, Sheraton Centre Toronto, Forest Hill ·         Chair/Discussant—Sara Mayeux, Vanderbilt University ·         Ingraham v. [read post]
28 Jul 2008, 5:45 pm
A recent study estimated the annual cost of E. coli O157:H7 illnesses to be $405 million (in 2003 dollars) which included $370 million for premature deaths, $30 million for medical care, and $5 million for lost productivity (Frenzen, Drake, and Angulo, 2005). [read post]
14 Mar 2024, 6:56 am by centerforartlaw
This iterative process continued in countries like India and China, each factory adding its own interpretation and modifications along the way.[17] Wiesner stated, “One thing we’re always so amazed by is the creativity that comes out of the half of the process when producing an object [in a factory]. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]